doi: 10.1016/0014-2999(84)90628-9.
5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain
- PMID: 6150862
- DOI: 10.1016/0014-2999(84)90628-9
Item in Clipboard
5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain
Eur J Pharmacol.
.
Abstract
The dopamine D1-receptor antagonist SCH 23390 was a potent competitive antagonist of 5HT-induced vasoconstriction in the isolated perfused rat tail artery preparation (pA2 8.17) but a very weak antagonist of phenylephrine-induced responses (pA2 5.94). In rat brain cerebral cortex, SCH 23390 inhibited 5-HT2-sensitive [3H]spiperone binding with an IC50 of 112 nM. Binding of [3H]5HT to 5HT1 receptors in the cortex was inhibited by SCH 23390 with an IC50 of 2.49 microM. SCH 23390 has significant affinity for 5HT receptors in addition to the reported selective dopamine D1-receptor antagonist properties.
Similar articles
-
The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.Eur J Pharmacol. 1986 Oct 7;129(3):367-70. doi: 10.1016/0014-2999(86)90449-8. Eur J Pharmacol. 1986. PMID: 3536532
-
Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.J Recept Res. 1988;8(1-4):107-20. doi: 10.3109/10799898809048981. J Recept Res. 1988. PMID: 3290470
-
A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.Eur J Pharmacol. 1992 Jan 21;210(3):279-84. doi: 10.1016/0014-2999(92)90416-2. Eur J Pharmacol. 1992. PMID: 1351844
-
Vascular serotonin receptors. Correlation with 5-HT1 and 5-HT2 binding sites.Biochem Pharmacol. 1984 Aug 1;33(15):2349-53. doi: 10.1016/0006-2952(84)90704-4. Biochem Pharmacol. 1984. PMID: 6380502 Review. No abstract available.
-
Serotonin (5HT) and its antagonists: involvement in the cardiovascular system.Clin Exp Pharmacol Physiol. 1984 Sep-Oct;11(5):439-55. doi: 10.1111/j.1440-1681.1984.tb00852.x. Clin Exp Pharmacol Physiol. 1984. PMID: 6098391 Review.
Cited by
-
Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis.Proc Natl Acad Sci U S A. 1990 Mar;87(6):2187-91. doi: 10.1073/pnas.87.6.2187. Proc Natl Acad Sci U S A. 1990. PMID: 2315313 Free PMC article.
-
A functional response to D1 dopamine receptor stimulation in the central nervous system: inhibition of the release of [3H]-serotonin from the rat substantia nigra.Naunyn Schmiedebergs Arch Pharmacol. 1987 May;335(5):502-7. doi: 10.1007/BF00169115. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 2956523
-
Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats.Psychopharmacology (Berl). 1993;113(1):110-8. doi: 10.1007/BF02244342. Psychopharmacology (Berl). 1993. PMID: 7862816
-
The benzazepine SCH 23390 increases plasma levels of cortisol in the conscious dog.Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):111-2. doi: 10.1007/BF00633207. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2869416
-
Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine.J Neurosci. 2001 Aug 1;21(15):5841-6. doi: 10.1523/JNEUROSCI.21-15-05841.2001. J Neurosci. 2001. PMID: 11466456 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
